BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

997 related articles for article (PubMed ID: 22780955)

  • 1. Mesenchymal stem cell: an efficient mass producer of exosomes for drug delivery.
    Yeo RW; Lai RC; Zhang B; Tan SS; Yin Y; Teh BJ; Lim SK
    Adv Drug Deliv Rev; 2013 Mar; 65(3):336-41. PubMed ID: 22780955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exosomes for drug delivery - a novel application for the mesenchymal stem cell.
    Lai RC; Yeo RW; Tan KH; Lim SK
    Biotechnol Adv; 2013; 31(5):543-51. PubMed ID: 22959595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mesenchymal stem cell exosome ameliorates reperfusion injury through proteomic complementation.
    Lai RC; Yeo RW; Tan KH; Lim SK
    Regen Med; 2013 Mar; 8(2):197-209. PubMed ID: 23477399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paclitaxel is incorporated by mesenchymal stromal cells and released in exosomes that inhibit in vitro tumor growth: a new approach for drug delivery.
    Pascucci L; Coccè V; Bonomi A; Ami D; Ceccarelli P; Ciusani E; Viganò L; Locatelli A; Sisto F; Doglia SM; Parati E; Bernardo ME; Muraca M; Alessandri G; Bondiolotti G; Pessina A
    J Control Release; 2014 Oct; 192():262-70. PubMed ID: 25084218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mesenchymal stem cell exosome: a novel stem cell-based therapy for cardiovascular disease.
    Lai RC; Chen TS; Lim SK
    Regen Med; 2011 Jul; 6(4):481-92. PubMed ID: 21749206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesenchymal-stem-cell-derived exosomes accelerate skeletal muscle regeneration.
    Nakamura Y; Miyaki S; Ishitobi H; Matsuyama S; Nakasa T; Kamei N; Akimoto T; Higashi Y; Ochi M
    FEBS Lett; 2015 May; 589(11):1257-65. PubMed ID: 25862500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exosome-formed synthetic microRNA-143 is transferred to osteosarcoma cells and inhibits their migration.
    Shimbo K; Miyaki S; Ishitobi H; Kato Y; Kubo T; Shimose S; Ochi M
    Biochem Biophys Res Commun; 2014 Mar; 445(2):381-7. PubMed ID: 24525123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiation increases the cellular uptake of exosomes through CD29/CD81 complex formation.
    Hazawa M; Tomiyama K; Saotome-Nakamura A; Obara C; Yasuda T; Gotoh T; Tanaka I; Yakumaru H; Ishihara H; Tajima K
    Biochem Biophys Res Commun; 2014 Apr; 446(4):1165-71. PubMed ID: 24667602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal stem cell exosomes.
    Lai RC; Yeo RW; Lim SK
    Semin Cell Dev Biol; 2015 Apr; 40():82-8. PubMed ID: 25765629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Isolation and Characterization of Exosome from Human Embryonic Stem Cell-Derived C-Myc-Immortalized Mesenchymal Stem Cells.
    Lai RC; Yeo RW; Padmanabhan J; Choo A; de Kleijn DP; Lim SK
    Methods Mol Biol; 2016; 1416():477-94. PubMed ID: 27236691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exosomes are endogenous nanoparticles that can deliver biological information between cells.
    Sun D; Zhuang X; Zhang S; Deng ZB; Grizzle W; Miller D; Zhang HG
    Adv Drug Deliv Rev; 2013 Mar; 65(3):342-7. PubMed ID: 22776312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exosomes as nucleic acid nanocarriers.
    van den Boorn JG; Dassler J; Coch C; Schlee M; Hartmann G
    Adv Drug Deliv Rev; 2013 Mar; 65(3):331-5. PubMed ID: 22750807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer exosomes trigger mesenchymal stem cell differentiation into pro-angiogenic and pro-invasive myofibroblasts.
    Chowdhury R; Webber JP; Gurney M; Mason MD; Tabi Z; Clayton A
    Oncotarget; 2015 Jan; 6(2):715-31. PubMed ID: 25596732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thiophene-based compounds as fluorescent tags to study mesenchymal stem cell uptake and release of taxanes.
    Duchi S; Dambruoso P; Martella E; Sotgiu G; Guerrini A; Lucarelli E; Pessina A; Coccè V; Bonomi A; Varchi G
    Bioconjug Chem; 2014 Apr; 25(4):649-55. PubMed ID: 24628247
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exosomes as therapeutics: The implications of molecular composition and exosomal heterogeneity.
    Ferguson SW; Nguyen J
    J Control Release; 2016 Apr; 228():179-190. PubMed ID: 26941033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exosomes as Tools to Suppress Primary Brain Tumor.
    Katakowski M; Chopp M
    Cell Mol Neurobiol; 2016 Apr; 36(3):343-52. PubMed ID: 26983831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exosomes derived from human bone marrow mesenchymal stem cells promote tumor growth in vivo.
    Zhu W; Huang L; Li Y; Zhang X; Gu J; Yan Y; Xu X; Wang M; Qian H; Xu W
    Cancer Lett; 2012 Feb; 315(1):28-37. PubMed ID: 22055459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exosomes from breast cancer cells can convert adipose tissue-derived mesenchymal stem cells into myofibroblast-like cells.
    Cho JA; Park H; Lim EH; Lee KW
    Int J Oncol; 2012 Jan; 40(1):130-8. PubMed ID: 21904773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microfluidic fabrication of cell-derived nanovesicles as endogenous RNA carriers.
    Jo W; Jeong D; Kim J; Cho S; Jang SC; Han C; Kang JY; Gho YS; Park J
    Lab Chip; 2014 Apr; 14(7):1261-9. PubMed ID: 24493004
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toward tailored exosomes: the exosomal tetraspanin web contributes to target cell selection.
    Rana S; Yue S; Stadel D; Zöller M
    Int J Biochem Cell Biol; 2012 Sep; 44(9):1574-84. PubMed ID: 22728313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 50.